Serratus Anterior Plane Block Versus Thoracic Paravertebral Block.

Not Applicable

• Conditions: Rib Fractures; Analgesia
• Interventions: Procedure: Serratus anterior plane block; Procedure: Thoracic Paravertebral block; Procedure: Control

• Registration Number: NCT04554186
• Lead Sponsor: Minia University

Brief Summary

Compare between serratus anterior plane block and thoracic Paravertebral block in analgesia for patients with multiple rib fractures

Detailed Description

The study will be conducted in a prospective randomised controlled. Patients will be allocated into three groups

Control group:

The patient will receive fentanyl patch 50 microgram

TPVB group:

The patient will receive thoracic vertebral plane lock 0.4ml/kg bupivacaine 0.1 25% will be administered. For continuous infusion catheter will be inserted . Then a rate of 7ml / hour to max 10 ml / hour of bupivacaine 0.0625%

SAPB group,:

Patient will receive serratus anterior plane block 0.4ml / kg bupivacaine 0.125% will be injected to open the space then a catheter will be advanced For continuous infusion of 0.0625 % bupivacaine at 7 ml / hour

Study Timeline

• Status Verified: 2020-09
• Study First Submitted: 2020-09-12
• Study First Submitted QC: 2020-09-12
• Study First Posted: 2020-09-18
• Study Start: 2020-09-22
• Last Update Submitted: 2020-09-22
• Last Update Posted: 2020-09-23
• Primary Completion: 2021-01-01
• Study Completion: 2021-01-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• ASA 1_3 Age 18_60 Unilateral fracture ribs

Exclusion Criteria

• Drug allergy Morbid obese Opioid dependence Patients refuse

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Serratus anterior plane block	Serratus anterior plane block	20 patients will receive SAP block with 0.4 ml / kg bupivacaine 0.125% then continuous infusion through a catheter at rate of 7 ml / hour to max 10 ml / hour of bupivacaine 0.0625%
Thoracic Paravertebral block	Thoracic Paravertebral block	20 patients will receive TPVB 0.4ml / kg bupivacaine 0.125% then continuous infusion through a catheter at rate of 7 ml / hour to max 10 ml / hour of bupivacaine 0.0625%
Control group	Control	20 patients will receive Fentanyl patch 50 microgram

Primary Outcome Measures

Name	Time	Method
VAS score	24 hour	Visual analogue pain score describe by the patient

Secondary Outcome Measures

Name	Time	Method
Total analgesic consumption	24 hour	Total opioid consume by the patient in 24 hour

Trial Locations

Locations (1)

Minia university hospital; 🇪🇬 Minya, Egypt